Pharmaceutical Technology

MAY 16, 2023

The Foundation for the National Institutes of Health (FNIH) has announced its plans to prioritise eight rare diseases to provide industry standards for manufacturing, preclinical testing and product analytical testing for gene therapy development. This will include pairing up indications with manufacturers amongst the BGTC’s partners.

Gene Therapy 227

Gene Therapy Gene Research Clinical Trials 227

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. He notes that there were preclinical stage companies that possibly went through an IPO with a degree of exaggeration. Manufacturing or salary discussions are also affected, notes Voigt.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

STAT News

JANUARY 27, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s Previously, he worked at Deep Genomics, where he was vice president and head of preclinical research. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

Genome 98

Genome Genomics Research 98

Drug Discovery World

MARCH 15, 2024

News round-up for 11-15 March by DDW Digital Content Editor Diana Spencer. The top stories: New drug shows promising neuroprotective effects Galimedix Therapeutics has announced data showing small molecule GAL-201 has neuroprotective and symptomatic alleviation potential in models of Alzheimer’s disease (AD).

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Adding to this, other events like the worldwide energy crisis and the ongoing conflict in Ukraine have led to global uncertainty, Skillington tells this news service.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

Drug Discovery World

FEBRUARY 23, 2024

News round-up for 19-23 February by DDW Digital Content Editor Diana Spencer. The top stories: Insulin independence without immunosuppression Preclinical data has demonstrated insulin independence following transplantation of hypoimmune (HIP) allogeneic primary islet cells without immunosuppression in a diabetic non-human primate (NHP).

Gene Therapy 52

Gene Therapy Insulin FDA Approval Drugs 52

Drug Discovery World

OCTOBER 27, 2023

News round-up for 23-27 October by DDW Digital Content Editor Diana Spencer. My news highlights this week feature a variety of treatment approaches, from cell therapy and antibody-drug conjugate to autotaxin inhibitor and arenaviral vaccine, all entering early in-human clinical trials to treat a range of diseases.

Drugs 52

Drugs Antibody Vaccination Vaccine 52

Drug Discovery World

AUGUST 18, 2023

News round-up for 14-18 August by DDW Digital Content Editor Diana Spencer. My chosen news stories this week all discuss pre-clinical research studies that could have a huge impact on our therapeutic approach to several hard-to-treat diseases, helping to overcome drug-resistance and make treatments more targeted in the future.

Drugs 52

Drugs Antibody Genetics Gene 52

BioTech 365

OCTOBER 1, 2021

Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2021 Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2021 STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), … Continue reading →

52

52

Drug Discovery World

DECEMBER 7, 2023

Dr Tomasz Kostrzewski, Chief Scientific Officer, CN Bio, said: “Inipharm’s progression to clinic is absolutely fantastic news and holds immense potential for patients worldwide.

Drugs 59

Drugs In-Vivo Gene Development 59

Pharmaceutical Technology

MAY 12, 2023

BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity. Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130

Drug Discovery World

OCTOBER 20, 2023

News round-up for 16-20 October by DDW Digital Content Editor Diana Spencer. To celebrate DDW’s first Turning Science into Business Summit on ‘Cancer research opportunities and advances’, the news round-up this week highlights the latest developments in oncology drug discovery.

Drugs 59

Drugs Research Medicine Marketing 59

STAT News

DECEMBER 22, 2022

What doesn’t change is that we’ve got the usual roundup of pharma news for you to read. Matthew Herper is here, filling in for Pharmalot, who is taking a well-deserved break, which means that today there’s English Breakfast tea instead of flavored coffee and two cozy cats instead of the usual mascot. billion.

Gene Therapy 98

Gene Therapy Gene Drugs Licensing 98

BioTech 365

OCTOBER 5, 2021

DGAP-News: Secarna Pharmaceuticals GmbH & Co. Secarna Pharmaceuticals announces publication of new preclinical data showing strong potential of LNAplusTM-based ASOs … Continue reading →

40

40

Drug Discovery World

JANUARY 15, 2024

The announcement follows the news that Merck agreed a deal with Inspirna for colorectal cancer drug ompenaclid (RGX-202). “At The acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumours.

Clinical Development 105

Clinical Development Clinical Trials Clinical Trials Development 105

Drug Discovery World

JANUARY 6, 2023

News round-up for 2-6 January by DDW Digital Content Editor Diana Spencer. The drug discovery industry has hit the ground running in 2023 with some big announcements in the first week, particularly in cancer research, where there has been good news in pancreatic, urothelial and uveal cancers. . The top stories: .

Drugs 52

Drugs Antibody Clinical Trials Clinical Trials 52

XTalks

JANUARY 3, 2024

billion with preclinical, development, regulatory and sales milestones. The two will also collaborate to advance a preclinical gene therapy candidate for HD, Voyager said in a news release. “We The total value of the deal could potentially reach $1.2 The agreement also includes a $20 million equity purchase in Voyager.

Gene Therapy 52

Gene Therapy Gene Licensing Licensing 52

Drug Discovery World

JANUARY 13, 2023

News round-up for 9-13 January by DDW Digital Content Editor Diana Spencer. Once again, research partnerships and licence agreements have dominated the news this week, as drug discovery companies seek new ways to combine their expertise to address unmet medical needs. . The top stories: . Cambrian expands fibrosis pipeline .

Drugs 52

Drugs Antibody RNA Engineer 52

pharmaphorum

OCTOBER 13, 2021

The news sent Swedish firm CombiGene’s shares soaring – almost doubling from SEK6.29 million excluding royalties and up to $50 million at preclinical and clinical milestones. Spark Therapeutics has secured the exclusive rights to CombiGene’s CG01 therapy, which aims to treat drug resistant focal epilepsy, in a deal worth $8.5m

Gene Therapy 57

Gene Therapy Clinical Trials Clinical Trials Production 57

Pharmaceutical Technology

APRIL 4, 2023

Next generation EGFR inhibitors in development News of this agreement followed Scorpion’s announcement of its development plans for STX-241. On April 3, the company said it selected the drug STX-241 as its next development candidate, and that it plans to present related preclinical data in H2 2023.

Cosmetics 130

Cosmetics Development Licensing Licensing 130

Drug Discovery World

JANUARY 12, 2024

News round-up for 8-12 January by DDW Digital Content Editor Diana Spencer. Perhaps most importantly, a new antibiotic was found that targets a Gram-negative pathogen, mRNA was used as an effective therapy for a rare liver disease, and a common immune cell was found to attack cancer.

Drugs 52

Drugs Immune Response Allergies Bacteria 52

Drug Discovery World

SEPTEMBER 8, 2023

News round-up for 4-8 September by DDW Digital Content Editor Diana Spencer. The post This week in drug discovery (4-8 September) appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Life Science Antibody Licensing 52

Drug Discovery World

OCTOBER 14, 2022

News round-up for 10-14 October by DDW Digital Content Editor Diana Spencer. The top news in the world of drug discovery this week reflects the vital importance of collaboration, partnership and support within this industry. . Collaboration extended in severe neuropsychiatric disorders .

Gene Editing 52

Gene Editing RNA Drugs Gene 52

Drug Discovery World

APRIL 28, 2023

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Macrophages suppress natural killer cells in lung cancer tumours Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer.

Drugs 52

Drugs Life Science Clinical Trials Clinical Trials 52

Drug Discovery World

JUNE 30, 2023

News round-up for 26-30 June by DDW Digital Content Editor Diana Spencer. This week we have heard about a number of studies that demonstrate an inventive solution to an old problem, either through the use of an original approach or new, advanced technology.

Allergies 52

Allergies Drugs Antibody Regulation 52

Drug Discovery World

APRIL 8, 2024

“We are thrilled to present our preclinical findings for ISB 2001 at AACR,” said Lida Pacaud, Chief Medical Officer of Ichnos Glenmark Innovation. ” Innovent Biologics Innovent Biologics presented preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from its oncology pipeline.

In-Vivo 52

In-Vivo In-Vitro Antibody Protein 52

Drug Discovery World

MARCH 24, 2023

News round-up for 20-24 March by DDW Digital Content Editor Diana Spencer. This week we have seen a number of developments in the treatment of solid tumours hitting the headlines.

Drugs 52

Drugs Hormones Trials Research 52

pharmaphorum

DECEMBER 24, 2021

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm.

Drugs 108

Drugs FDA Approval Trials Marketing 108

Drug Discovery World

MARCH 3, 2023

News round-up for 27 February – 3 March by DDW Digital Content Editor Diana Spencer. As well as providing extensive coverage of the SLAS2023 meeting in San Diego and Rare Disease Day , DDW has also reported on a number of developments in cancer drug discovery this week.

Drugs 52

Drugs Gene Expression Genome Genomics 52

The Pharma Data

JANUARY 18, 2021

These preclinical results are very encouraging; they show that SENS-401 may have the potential to assist cochlear implant patients with an otoprotective effect, improving outcomes. ”. The preclinical program was conducted as part of a collaboration between Sensorion and Cochlear (ASX: COH), the global leader in implantable hearing solutions.

Containment 52

Containment Gene Therapy Gene Development 52

pharmaphorum

SEPTEMBER 10, 2020

That could be important if it takes longer than expected to bring vaccines and antibodies to market, said a spokesman for the companies, pointing to the news this week that AstraZeneca has halted phase 3 trials of its COVID-19 vaccine candidate AZD1222 after a serious adverse reaction in one patient.

Vaccination 128

Vaccination Vaccine Bacterium Antibody 128

pharmaphorum

DECEMBER 2, 2021

As the UK approval was announced, GSK said it has preclinical testing results which have found that the antibody retains activity against “all tested variants of concern, including key mutations of Omicron.” BREAKING NEWS: A new treatment against COVID-19 has been approved by @MHRAgovuk.

Antibody 109

Antibody Regulation Clinical Trials Clinical Trials 109

pharmaphorum

MAY 18, 2022

The news follows a report in Endpoints last month that SwanBio had laid off around quarter of its workforce after struggling to finalise the funding round.

Gene Therapy 88

Gene Therapy Gene Trials Clinical Trials 88

Drug Discovery World

DECEMBER 29, 2022

In an increasingly busy world, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers informed on the latest industry news and updates. Exploring the microbiome: how it is shaping preclinical research . In October 2022, the DDW Highlights podcast series was launched. Episodes are released weekly.

Recombinant DNA Technology 52

Recombinant DNA Technology Genome Genomics DNA 52

pharmaphorum

JULY 16, 2021

While the company put a brave face on the results, saying they provide clinical evidence of the potential role of SIK inhibition in treating inflammation, there’s no disguising the disappointment as GLPG3970 steps aside for follow-up candidates in preclinical development. Gilead was unaffected by the news and its shares firmed slightly.

Trials 57

Trials Drugs Clinical Trials Clinical Trials 57

XTalks

OCTOBER 12, 2021

Much to our happy surprise, the rheumatoid arthritis totally disappeared in animals that received a vaccine,” Dr. Chakravarti said in a news release from UToledo. And on World Arthritis Day, this is very hopeful news for the millions of sufferers of the disease. Sometimes there is no better way than serendipity.

Vaccination 105

Vaccination Vaccine Research Immune Response 105

The Pharma Data

JANUARY 25, 2021

The AD-SAB will work closely with NervGen as the Company plans its upcoming preclinical studies and clinical trials and in the analyses of the results from these studies. He has developed new diagnostic tests for Alzheimer’s disease, as well as new preclinical models. for the latest news on the Company.

Clinical Development 40

Clinical Development Containment Development Research 40